This inventor holds 1 USPTO granted patent. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations of Sung-Jin Lee in Endothelial Cell Research.
Introduction
Sung-Jin Lee is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of biomedical research, particularly in the area of endothelial cell interactions.
Latest Patents
Sung-Jin Lee holds a patent for the use of a peptide that interacts with the αvβ3 integrin of endothelial cells. This invention focuses on a method for inhibiting endothelial cell adhesion, migration, and angiogenesis. The peptide consists of at least 18 amino acids, including tyrosine-histidine (TY) or asparagines-histidine (NH), along with at least three hydrophobic amino acids with bulky side chains. Furthermore, this invention provides a method for treating or preventing diseases related to angiogenesis.
Career Highlights
Sung-Jin Lee is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work emphasizes the importance of peptide interactions in medical applications, showcasing his dedication to advancing scientific knowledge.
Collaborations
He has collaborated with notable colleagues, including Ju-Ock Nam and Jung-Eun Kim, to further enhance research outcomes in his field.
Conclusion
Sung-Jin Lee's innovative work in endothelial cell research and his patented methods highlight his significant contributions to biomedical science. His efforts continue to pave the way for advancements in treating angiogenesis-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile